A-705253
/ AbbVie
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 08, 2019
Platelet-derived Calpain Mediates Protease-activated Receptor 1-dependent Vascular Inflammation in Diabetes
(ISTH 2019)
- "These data demonstrate that platelet-derived calpains contribute to diabetes-associated vascular inflammation by targeting the PAR-1 receptor and suggest calpain as a therapeutic target to treat diabetes-associated cardiovascular complications."
1 to 1
Of
1
Go to page
1